What is the rating for STSS stock?

Sharps Technology Inc. (STSS) has a "Avoid" rating based on our 6-factor quantitative model. It has a composite score of 29.9 and ranks #4532 out of 7,333 stocks in our coverage universe with a 1-star rating.

Is STSS a good stock to buy?

Based on our quantitative analysis, STSS receives a "Avoid" rating with 1 out of 5 stars. Key factors include: Quality score of 18.5, Value score of 0, and Momentum score of 49.1. The timing score is 35, indicating "Bearish" entry conditions. This is not investment advice - please conduct your own research.

What sector is STSS in?

Sharps Technology Inc. (STSS) operates in the Manufacturing sector, specifically in the Medical Equipment industry. It has a market capitalization of $0.01 billion.

What is STSS's P/E ratio?

P/E ratio data is not currently available for STSS.

Does STSS pay a dividend?

STSS does not currently pay a dividend.

What is STSS's market cap?

Sharps Technology Inc. (STSS) has a market capitalization of $0.01 billion, making it a micro-cap stock.

What are the risks of investing in STSS?

Key risk factors for STSS include: higher volatility, and general market risk. As with all investments, there is risk of loss.

How does STSS compare to peers?

Within the Manufacturing sector, STSS ranks #4532 overall with a quality score of 18.5/100 and value score of 0/100.

What is STSS's revenue growth?

Revenue growth data is not currently available for STSS.

What is STSS's composite score?

Sharps Technology Inc. (STSS) has a composite score of 29.9/100, which places it at rank #4532 out of 7,333 stocks. This score is derived from our proprietary 6-factor quantitative model that evaluates quality, value, momentum, investment efficiency, stability, and short interest.

How does STSS compare to the S&P 500?

STSS ranks in the top 38% of all stocks in our coverage universe with a composite score of 29.9. This places it below the market median.

What are the bull and bear cases for STSS?

Bull case: STSS scores highest in short interest at 61.6/100, indicating strong performance in this area. Bear case: The weakest factor is value at 0/100, which may present a risk. Our overall assessment is Avoid with 1 out of 5 stars.

Is STSS overvalued or undervalued?

STSS appears overvalued based on our value factor score of 0/100.

What is STSS's momentum score?

STSS has a momentum score of 49.1/100, placing it in the moderate category.

When is STSS's next earnings date?

For the latest earnings date and analysis for STSS, visit our earnings calendar or check the STSS stock page for real-time updates. Our AI-generated earnings reports provide in-depth analysis after each quarterly report.

Is STSS a good stock to buy right now?

Based on our 6-factor quantitative model, Sharps Technology Inc. (STSS) receives a "Avoid" rating with a composite score of 29.9/100. It is ranked #4532 out of 7,333 stocks. Key factor scores: Quality 19/100, Value 0/100, Momentum 49/100. The timing signal is "Bearish". This is quantitative analysis only — not investment advice.

What is the stock rating for STSS?

Sharps Technology Inc. (STSS) has a "Avoid" rating and 1-star score. The composite score of 29.9 ranks it #4532 among 7,333 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is STSS in?

Sharps Technology Inc. operates in the Manufacturing sector (Medical Equipment industry) with a market cap of $7 million. It is classified as a micro-cap stock.

Does STSS pay a dividend?

STSS does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is STSS's P/E ratio?

P/E ratio data is not currently available for STSS, which may indicate the company is not yet profitable.

How profitable is STSS?

STSS's quality factor score is 19/100. Gross margin: -463.4%. ROE: -23.4% vs sector average -1.9%. Margins are moderate to low, reflecting competitive market dynamics.

How is STSS valued compared to peers?

STSS's value factor score is 0/100 (higher = cheaper). Key multiples: . Trading at a premium relative to peers.

What is STSS's debt level?

STSS's debt-to-equity ratio is 2%. Sector average: 0%. Low leverage suggests conservative financial management.

STSS has a beta of -1.40, meaning it is less volatile than the market. Stability score: 27/100.

Does STSS have high short interest?

STSS's short interest factor score is 62/100 (higher = less short selling). Moderate short interest.

STSS Stock Analysis — Sharps Technology Inc. Price Target & Forecast 2026

IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.

HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.

RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.

STSS Stock Analysis — Sharps Technology Inc. Price Target & Forecast 2026 | Blank Capital Research

Sector

Manufacturing

Industry

Medical Equipment

Market Cap

$7M

Leadership

Robert M. Hayes

Business Summary

Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Operations

Headcount

Location

HQ Base

Pending Verification

Investor Relations

Fundamental Spot Check

Context: 2025

Valuation

Market Cap

$7M

P/E Ratio

P/B Ratio

0.12xOutperforming

P/S Ratio

41.47xLagging

EV/EBITDA

Dividend Yield

0.00%

Efficiency & Risk

Gross Margin

-463.4%Lagging

Operating Margin

-5629.9%Lagging

ROE

-23.4%Lagging

Rev Growth (YoY)

Debt/Equity

2.00xLagging

Beta

-1.40

Red = Sector Laggard

Black = Market Average

Revenue Breakdown

Strategic Timing Audit

WEAK

0/6

Negative Alignment — Extreme Caution

Quantitative Factor Convergence Analysis Verified

Momentum

49th pctl

Intelligence Feed

BenzingaJul 5 Negative

Gold Gains Over 1%; NIO Shares Slide - Koss (NASDAQ:KOSS) - Benzinga

U.S. stocks traded mostly higher on Friday, with the Nasdaq Composite gaining over 150 points. Gold prices rose over 1%, while NIO shares slid 6% after the company's CFO resigned.

yahooFeb 7 Negative

Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results

As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana

BenzingaJul 5 Positive

Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Sharps ... - Benzinga

Sharps Technology shares jumped 31.7% in pre-market trading after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery. Several other stocks also saw significant pre-market movements.

benzinga.comJan 9 Negative

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.comJan 9 Positive

12 Health Care Stocks Moving In Friday's Pre-Market Session

Earnings Call Transcripts

Unlock Valuation Tools

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Financial Intelligence Ledger

Verified SEC Filings Aggregate • STSS

Export

Metric Entity	10Y Historical Trend	2024	2023	2022	2021
Revenue		$0	$0	$0	$0
Cost of Revenue	-	—	—	—	—
Gross Profit		$0	—	—	$0
R&D Expense		$2M54.0%	$2M29.6%	$2M34.9%	$2M
Operating Expenses	-	—	—	—	—
Operating Income		-$10M4.9%	-$10M15.9%	-$9M94.3%	-$4M
Interest Expense		$2M	—	—	$167K
Tax Provision	-	-$30K	—	—	—
EBITDA		-$5M43.9%	-$9M14.4%	-$8M87.6%	-$4M
Net Income		-$9M5.5%	-$10M112.1%	-$5M0.5%	-$5M
EPS (Diluted)		$-7.40873.7%	$-0.7633.3%	$-0.5740.6%	$-0.96

SEC EDGAR Repository

Direct unfiltered access to 10-K, 10-Q and 8-K filings for STSS.

Open Regulatory Dossier

Data Integrity Notice

Figures adjusted for stock splits and restatements where applicable.

TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.

Execution Benchmarks Audit

Gross Margin

Core pricing power

-1152% SCTR

-463.4%

Sector Avg: 44.1%

Operating Margin

Operating efficiency

-224399% SCTR

-5629.9%

Sector Avg: 2.5%

Return on Equity

Equity efficiency

+1134% SCTR

-23.4%

Sector Avg: -1.9%

Debt/Equity

Financial leverage

-852% SCTR

2.0%

Sector Avg: 0.2%

Dividend Yield

Direct cash return

-NaN% SCTR

0.0%

Sector Avg: 0.0%

Financial History

Forensic Accounting Audit

Verified

Insufficient data for Financial Analysis

Algorithmic red flag detection based on regulatory SEC filings.

Unlock Financial Statements

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Shareholder Returns

Capital Allocation audit

Smart Money Conviction

Neutral

Synthesized from recent 13F filings, Form 4 insider transactions, and outstanding short interest metrics.

Governance Audit

Weak Index

WeakModerateStrong

Lower quality and stability scores may indicate governance concerns. Verified against factor-based integrity benchmarks.

Executive Operations

CEO: Robert M. Hayes

Insider alignment Audit

No recent insider transactions available for STSS

Major Institutional Blocks

Top 5 Holders

Institutional cap table data requires verified 13F filing feeds.

Access SEC 13F Dossier →

Form 4 Filings

Recent Activity

Insider transaction data currently awaiting regulatory verification.

Access SEC Form 4 Dossier →

Regulatory Disclosure Vault

Proxy Statement (DEF 14A)

Exec Comp, Board Nominees, Proposals

Annual Report (10-K)

MD&A, Risk Factors, Strategy

Institutional Holders (13F)

Loading institutional data...

Insider Liquidity

Short Interest audit

SEC Risk Factors

Unlock Governance & Ownership

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Factor Analysis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Investment Thesis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Institutional Peer Matrix

Top Manufacturing Universe

Stock	Rating	Score▼	Quality	Value	Momentum	P/E	EV/EBITDA	ROE	ROA	Gross Mgn	Op Mgn	Net Mgn	Rev Growth	Div Yield	D/E	Mkt Cap	AUDIT
$UL UNILEVER PLC		78	96	98	59	-	-	-	-	-	-	-	-	-	-	$0	VS
$ASML ASML HOLDING NV		77	89	86	83	-	-	-	-	-	-	-	-	-	-	$0	VS
$ESLT ELBIT SYSTEMS LTD		76	81	87	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$MT ArcelorMittal		75	71	98	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$AMAT APPLIED MATERIALS INC /DE		75	85	87	84	20.9x	13.6x	32.9%	20.5%	48.8%	30.6%	24.4%	7.7%	0.9%	32.0x	$148.6B	VS
$SIMO Silicon Motion Technology CORP		75	84	86	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$CODA Coda Octopus Group, Inc.		74	83	90	79	16.3x	11.9x	7.4%	7.5%	68.3%	19.5%	18.2%	29.0%	0.0%	0.0x	$84M	VS
$GSK GSK plc		74	84	90	70	-	-	-	-	-	-	-	-	-	-	$0	VS
$EFXT Enerflex Ltd.		74	80	91	83	-	-	-	-	-	-	-	-	-	-	$0	VS
$BUD Anheuser-Busch InBev SA/NV		74	84	97	63	-	-	-	-	-	-	-	-	-	-	$0	VS
$STSS Sharps Technology Inc.		30	19	0	49	-	-	-23.4%	-22.9%	-463.4%	-5629.9%	-4285.8%	-	0.0%	2.0x	$7M
SECTOR BENCH	-	-	-	-	-	22.3x	11.5x	-1.9%	0.9%	44.1%	2.5%	1.0%	6.7%	0.0%	0.2x	-	REF

Access Full Manufacturing Intelligence Archive →

Lateral Comparison Mesh

$STSS / $UL AUDIT $STSS / $ASML AUDIT $STSS / $ESLT AUDIT $STSS / $MT AUDIT $STSS / $AMAT AUDIT

Market Intelligence FAQ

Sharps Technology Inc. (STSS) receives a "Avoid" rating with a composite score of 29.9/100. It ranks #4532 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.

Full Research Publication

Equity Research Analysis: Sharps Technology Inc. (STSS)

FEBRUARY 2026|Blank Capital Research Unit|Spot: $1.76

Price$1.76

Composite Score29.9/100

RatingAVOID (1★)

Rank#4532 OF 7,333

Market Cap$7M

Comments

Institutional Audit

Feb 25, 2026

Sharps Technology Inc.

29.9

Sector Decomposition auditManufacturing [N=1000]

Factor	Global	Sector	Tilt
PROFITABILITY	19	2	+17ALPHA
MOMENTUM	49	43	+6ALPHA
VALUATION	0	0	0NEUTRAL
INVESTMENT	19	2	+17ALPHA
STABILITY	27	11	+16ALPHA
SHORT INT	62	73	-11DRAG

Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.

Executive Summary

Our quantitative model flags Sharps Technology Inc. with an Avoid rating, assigning a composite score of 29.9/100 and 1 out of 5 stars. Ranked #4532 of 7,333 stocks, STSS falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.

Business Quality

Sharps Technology Inc. registers a weak quality score of just 19/100, indicating significant profitability challenges. The company reports a return on equity of -23.4% (sector avg: -1.9%), gross margins of -463.4% (sector avg: 44.1%), net margins of -4285.8% (sector avg: 1.0%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.

Intrinsic Valuation

STSS registers a value score of just 0/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.12x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.

Capital Reinvestment

Sharps Technology Inc.'s investment score of 19/100 suggests limited reinvestment activity. Key growth metrics include a return on assets of -22.9% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.

Market Momentum

STSS is currently showing below-average momentum at 49/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth data is not currently available, while a beta of -1.40 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.

Balance Sheet Health

STSS's stability score of 27/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -1.40 and a debt-to-equity ratio of 2.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.

Institutional Risk Profile

STSS carries a short interest score of 62/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include micro-cap liquidity risk. At $7M market cap (micro-cap), Sharps Technology Inc. offers reasonable institutional liquidity.

Sector Benchmark Analysis

Sharps Technology Inc. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4532 of 7,333 overall (38th percentile). Key comparisons include ROE of -23.4% trailing the -1.9% sector median and operating margins of -5629.9% below the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.

Comparative Research Mesh

STSS VS S&P 500 (SPY)TOP MANUFACTURING PEERS

Strategic Alternatives

While STSS currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.

View Top Manufacturing Alpha →

STSS

Sharps Technology Inc.

Business Summary

Operations

Location

Fundamental Spot Check

Valuation

Efficiency & Risk

Intelligence Feed

Gold Gains Over 1%; NIO Shares Slide - Koss (NASDAQ:KOSS) - Benzinga

Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results

Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Sharps ... - Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Unlock Valuation Tools

Unlock Financial Statements

Unlock Governance & Ownership

Unlock Factor Analysis

Unlock Investment Thesis

Lateral Comparison Mesh

Comments

Unlock Performance & Technicals

Economic Moat Audit

Economic Value Creation

Margin Superiority

Reinvestment Efficiency

Growth Durability

Financial Resilience

Uncertainty Audit

01Executive Summary

02Strategy & Outlook

Risk / Reward Variance

Research Verdict

Related Stocks

Executive Summary

Business Quality

Intrinsic Valuation

Capital Reinvestment

Market Momentum

Balance Sheet Health

Institutional Risk Profile

Sector Benchmark Analysis

Comparative Research Mesh

Strategic Alternatives

Factor Dispersion Audit

Sector Variance Findings

Intelligence Feed

Gold Gains Over 1%; NIO Shares Slide - Koss (NASDAQ:KOSS) - Benzinga

Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results

Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Sharps ... - Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Market Intel